Convergence Investment Partners’s AngioDynamics ANGO Stock Holding History

Convergence Investment Partners’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-27,873	Closed	-$606K	–	308
2018 Q3	$606K	Buy	+27,873	New	+$619K	0.12%	191
2018 Q2	–	Sell	-89,685	Closed	-$1.55M	–	336
2018 Q1	$1.55M	Buy	89,685 +2,736	+3%	+$45.6K	0.2%	176
2017 Q4	$1.45M	Sell	86,949 -3,960	-4%	-$67.6K	0.19%	195
2017 Q3	$1.55M	Sell	90,909 -6,711	-7%	-$113K	0.22%	176
2017 Q2	$1.58M	Buy	97,620 +16,550	+20%	+$262K	0.23%	165
2017 Q1	$1.41M	Sell	81,070 -11,626	-13%	-$194K	0.2%	195
2016 Q4	$1.56M	Buy	+92,696	New	+$1.55M	0.22%	191

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Convergence Investment Partners's ANGO Position: Q4 2018 in Review

Convergence Investment Partners sold out of AngioDynamics (ANGO) in Q4 2018, closing a stake of 27,873 shares — an estimated $606K sold.

Convergence Investment Partners first reported a position in ANGO in Q4 2016 and held it in 7 quarters. The position peaked at $1.58M in Q2 2017. 174 funds tracked by Wall St. Rank hold ANGO as of Q4 2018.

Convergence Investment Partners reported no remaining AngioDynamics position as of Q4 2018 after selling out during the quarter.
Convergence Investment Partners sold 27,873 AngioDynamics shares in Q4 2018, an estimated $606K.
Convergence Investment Partners first reported a position in AngioDynamics in Q4 2016 and held it in 7 quarters.
Convergence Investment Partners's AngioDynamics position peaked at $1.58M in Q2 2017.
174 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2018.

Based on Convergence Investment Partners's 13F filing for Q4 2018, filed 13 Feb 2019.